Long-term oral lysine supplementation in lysinuric protein intolerance

Metabolism: Clinical and Experimental

Volumn 56, Issue 2, 2007, Pages 185-189

  Tanner, Laura M ^a   Näntö Salonen, Kirsti ^a   Niinikoski, Harri ^a   Huoponen, Kirsi ^a   Simell, Olli ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLBUTYRIC ACID DERIVATIVE; BENZOIC ACID; CITRULLINE; LYSINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERAMMONEMIA; LONG TERM CARE; LOW DRUG DOSE; LYSINURIC PROTEIN INTOLERANCE; MALE; MEAL; PRIORITY JOURNAL; PROTEIN INTOLERANCE; SUPPLEMENTATION; TREATMENT DURATION;

ADOLESCENT; ADULT; AMINO ACID METABOLISM, INBORN ERRORS; AMINO ACIDS; AMMONIA; CALCIUM; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, ION EXCHANGE; CITRULLINE; DIETARY SUPPLEMENTS; FEMALE; FINLAND; HUMANS; LONG-TERM CARE; LYSINE; MALE; MIDDLE AGED; PHOSPHATES;

EID: 33846120107     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.09.011     Document Type: Article

References (22)

1. Simell O. Lysinuric protein intolerance and other cationic aminoacidurias. In: Scriver C.S., Beaucert A.L., Sly W.S., and Valle D. (Eds). The metabolic and molecular bases of inherited disease (2001), McGraw-Hill, New York 4933-4956
2. +LAT-1, as the lysinuric protein intolerance gene. Nat Genet 21 (1999) 293-296
3. Borsani G., Bassi M.T., Sperandeo M.P., et al. SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance. Nat Genet 21 (1999) 297-301
4. +LAT-1 amino acid transporter gene causing lysinuric protein intolerance (LPI). Hum Mol Genet 9 (2000) 431-438
5. Rajantie J., Simell O., and Perheentupa J. Basolateral membrane transport defect for lysine in lysinuric protein intolerance. Lancet 1 (1980) 1219-1221
6. Simell O., Perheentupa J., Rapola J., Visakorpi J.K., and Eskelin L.-E. Lysinuric protein intolerance. Am J Med 59 (1975) 229-240
7. Parto K., Kallajoki M., Aho H., and Simell O. Pulmonary alveolar proteinosis and glomerulonephritis in lysinuric protein intolerance: case reports and autopsy findings of 4 pediatric patients. Hum Pathol 25 (1994) 400-407
8. Rajantie J., Simell O., and Perheentupa J. Intestinal absorption in lysinuric protein intolerance: impaired for diamino acids, normal for citrulline. Gut 21 (1980) 519-524
9. Rajantie J., Simell O., Rapola J., and Perheentupa J. Lysinuric protein intolerance: a two-year trial of dietary supplementation therapy with citrulline and lysine. J Pediatr 97 (1980) 927-932
10. Awrich A.E., Stackhouse W.J., Cantrell J.E., Patterson J.H., and Rudman D. Hyperdibasicaminoaciduria, hyperammonemia and growth retardation: treatment with arginine, lysine, and citrulline. J Pediatr 87 (1975) 731-738
11. Kato T., Sano M., and Mizutani N. Inhibitory effect of intravenous lysine infusion on urea cycle metabolism. Eur J Pediatr 146 (1987) 56-58
12. Lukkarinen M., Näntö-Salonen K., Pulkki K., Mattila K., and Simell O. Effect of lysine infusion on urea cycle in lysinuric protein intolerance. Metabolism 49 (2000) 621-625
13. Lukkarinen M., Näntö-Salonen K., Pulkki K., Aalto M., and Simell O. Oral supplementation corrects plasma lysine concentrations in lysinuric protein intolerance. Metabolism 52 (2003) 935-938
14. Rajantie J. Orotic aciduria in lysinuric protein intolerance: dependence on the urea cycle intermediates. Pediatr Res 15 (1981) 115-119
15. Cree T.C., and Schalch D.S. Protein utilization in growth: effect of lysine deficiency on serum growth hormone, somatomedins, insulin, total thyroxine (T4) and triiodothyronine, free T4 index, and total corticosterone. Endocrinology 117 (1985) 667-673
16. Carpenter T.O., Levy H.L., Holtrop M.E., Shih V.E., and Anast C.S. Lysinuric protein intolerance presenting as childhood osteoporosis: clinical and skeletal response to citrulline therapy. N Engl J Med 312 (1985) 290-294
17. Svedström E., Parto K., Marttinen M., Virtama P., and Simell O. Skeletal manifestations of lysinuric protein intolerance: a follow-up study of 29 patients. Skeletal Radiol 22 (1993) 11-16
18. Parto K., Penttinen R., Paronen I., Pelliniemi L., and Simell O. Osteoporosis in lysinuric protein intolerance. J Inherit Metab Dis 16 (1993) 441-450
19. Likins R.C., Bavetta L.A., and Posner A.S. Calcification in lysine deficiency. Arch Biochem Biophys 70 (1957) 401-412
20. Civitelli R., Villareal D.T., Agnusdei D., Nardi P., Avioli L.V., and Gennari C. Dietary l-lysine and calcium metabolism in humans. Nutrition 8 (1992) 400-405
21. Lukkarinen M., Parto K., Ruuskanen O., et al. B and T cell immunity in patients with lysinuric protein intolerance. Clin Exp Immunol 116 (1999) 430-434
22. Lukkarinen M., Näntö-Salonen K., Ruuskanen O., et al. Varicella and varicella immunity in patients with lysinuric protein intolerance. J Inherit Metab Dis 21 (1998) 103-111